English | 繁體

Search in the results

UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Oxyberberine, a novel gut microbiota-mediated metabolite of berberine, possesses superior anti-colitis effect: Impact on intestinal epithelial barrier, gut microbiota profile and TLR4-MyD88-NF-κB pathway Journal article
Cailan Li, Gaoxiang Ai, Yongfu Wang, Qiang Lu, Chaodan Luo, Lihua Tan, Guosheng Lin, Yuhong Liu, Yucui Li, Huifang Zeng, Jiannan Chen, Zhixiu Lin, Yanfang Xian, Xiaoqi Huang, Jianhui Xie, Ziren Su. Oxyberberine, a novel gut microbiota-mediated metabolite of berberine, possesses superior anti-colitis effect: Impact on intestinal epithelial barrier, gut microbiota profile and TLR4-MyD88-NF-κB pathway[J]. PHARMACOLOGICAL RESEARCH, 2020, 152.
Authors:  Cailan Li;  Gaoxiang Ai;  Yongfu Wang;  Qiang Lu;  Chaodan Luo; et al.
Favorite | TC[WOS]:179 TC[Scopus]:195  IF:9.1/9.0 | Submit date：2021/12/06
Gut Microflora  Intestinal Epithelial Barrier  Metabolite  Oxyberberine  Tlr4-myd88-nf-κb  Ulcerative Colitis  
Dihydroberberine, a hydrogenated derivative of berberine firstly identified in Phellodendri Chinese Cortex, exerts anti-inflammatory effect via dual modulation of NF-κB and MAPK signaling pathways Journal article
Tan, L., Wang, Yongfu, Ai, Gaoxiang, Luo, Chaodan, Chen, Hanbin, Li, Cailan, Zeng, Huifang, Xie, Jianhui, Chen, Jiannan, Su, Z.. Dihydroberberine, a hydrogenated derivative of berberine firstly identified in Phellodendri Chinese Cortex, exerts anti-inflammatory effect via dual modulation of NF-κB and MAPK signaling pathways[J]. International Immunopharmacology, 2019, 75.
Authors:  Tan, L.;  Wang, Yongfu;  Ai, Gaoxiang;  Luo, Chaodan;  Chen, Hanbin; et al.
Favorite | TC[WOS]:23 TC[Scopus]:29  IF:4.8/5.0 | Submit date：2022/05/17
Anti-inflammatory  Dihydroberberine  Inflammatory Mediators  Mapk  Nf-κb  Phellodendri Chinese Cortex